Latest News about PILL
Recent news which mentions PILL
Top Performing Leveraged/Inverse ETFs: 08/17/2025
August 19, 2025
From ETF Trends
CURE: Make an Adventurous Bet on an Undervalued Sector
August 12, 2025
From ETF Trends
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
August 01, 2025
From Benzinga
From Benzinga
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
July 11, 2025
From Benzinga
From Benzinga
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
From Benzinga
Can Biotech Heal Itself?
July 30, 2024
From ETF Trends
Top Performing Leveraged/Inverse ETFs: 07/28/2024
July 30, 2024
From ETF Trends
Top Performing Leveraged/Inverse ETFs: 07/14/2024
July 16, 2024
From ETF Trends
Finding Opportunity in Unloved Healthcare ETFs
May 31, 2024
From ETF Trends
Top Performing Leveraged/Inverse ETFs: 02/18/2024
February 21, 2024
From ETF Trends
Top Performing Leveraged/Inverse ETFs: 09/11/2022
September 13, 2022
From ETF Trends
Top Performing Leveraged/Inverse ETFs: 06/26/2022
June 29, 2022
From ETF Trends
Top Performing Leveraged/Inverse ETFs: 11/07/2021
November 09, 2021
From ETF Trends
3 ETFs to Access a Changing Pharmaceutical Industry
August 16, 2021
From ETF Trends
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.